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Abstract
Background: Intraoperative fluid therapy guided by mechanical ventilation-induced pulse-pressure variation (PPV)
may improve outcomes after major surgery. We tested this hypothesis in a multi-center study.
Methods: The patients were included in two periods: a first control period (control group; n = 147) in which
intraoperative fluids were given according to clinical judgment. After a training period, intraoperative fluid
management was titrated to maintain PPV < 10% in 109 surgical patients (PPV group). We performed 1:1
propensity score matching to ensure the groups were comparable with regard to age, weight, duration of surgery, and
type of operation. The primary endpoint was postoperative hospital length of stay.
Results: After matching, 84 patients remained in each group. Baseline characteristics, surgical procedure duration and
physiological parameters evaluated at the start of surgery were similar between the groups. The volume of crystalloids
(4500 mL [3200-6500 mL] versus 5000 mL [3750-8862 mL]; P = 0.01), the number of blood units infused during the
surgery (1.7 U [0.9-2.0 U] versus 2.0 U [1.7-2.6 U]; P = 0.01), the fraction of patients transfused (13.1% versus 32.1%;
P = 0.003) and the number of patients receiving mechanical ventilation at 24 h (3.2% versus 9.7%; P = 0.027) were
smaller postoperatively in PPV group. Intraoperative PPV-based improved the composite outcome of
postoperative complications OR 0.59 [95% CI 0.35-0.99] and reduced the postoperative hospital length of stay
(8 days [6-14 days] versus 11 days [7-18 days]; P = 0.01).
Conclusions: In high-risk surgeries, PPV-directed volume loading improved postoperative outcomes and decreased
the postoperative hospital length of stay.
Trial Registration: ClinicalTrials.gov Identifier; retrospectively registered- NCT03128190
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Background
Major surgeries in high-risk patients are associated with
the development of postoperative complications, with
mortality rates ranging from 15 to 30% [1–3]. Intraop-
erative hemodynamic strategies aiming to maintain
adequate oxygen delivery have been shown to reduce
morbidity, mortality, and postoperative length of hos-
pital stay in several publications [4–7].
Despite the evidence favoring intraoperative hemody-
namic optimization in high-risk patients, [8] the role of
each intervention in increasing oxygen delivery remains
unclear. This is particularly true of fluid loading. Volume
management in the perioperative period plays a pivotal
role in resuscitation and, hence, morbidity and mortality
in surgical patients [2]. Excessive fluid administration
may aggravate pulmonary dysfunction, prolong the need
for mechanical ventilation, extend the hospital length of
stay and increase postoperative mortality [9].
Accurate prediction of fluid responsiveness may identify
patients who would benefit from volume expansion, and
prevent unnecessary fluid loading [10, 11]. Previous stud-
ies have demonstrated that pulse pressure variation (PPV)
is an accurate predictor of fluid responsiveness during
mechanical ventilation [12, 13]. Patients who have reached
the plateau of the Frank-Starling relationship can be iden-
tified as patients in whom PPV is lower than 13% [14].
The intraoperative goal of maximizing stroke volume by
volume loading can therefore be achieved simply by
maintaining a PPV below 13% [13, 15]. In this study, we
investigated whether PPV-guided intraoperative fluid
loading in high-risk surgical patients improves postopera-
tive outcomes.
Methods
This open label, multicenter, before-and-after trial study
was carried out in three hospitals, Hospital das Clínicas of
São Paulo University Medical School, Hospital São Paulo
of São Paulo Federal University and Hospital Padre
Albino. An independent Data Monitoring Committee
reviewed unblinded data for patient safety, and after the
pilot trial [13], this committee recommended that a
before-and-after study would be more adequate to avoid
clinical evidence possibility of inadequate treatment in
control group. The protocol was immediately amended in
accordance with that recommendation, and participants
were subsequently assigned in before and after periods.
Subsequently obtaining IRB approval (Ethical Commit-
tee N° 0616/06 HCFMUSP) and written informed con-
sent, high-risk patients undergoing open major surgery
under general anesthesia and who required ICU admis-
sion postoperatively were enrolled from June 2007 to
April 2008 (control period), followed by a phase-out
period (April 2008 to July 2008) and an intervention
period (July 2008 to June 2010).
High-risk surgical patients were defined as those
60 years of age or older referred to postoperative ICU
care due to the presence of at least one clinical comor-
bidity such as coronary artery disease, chronic obstruct-
ive pulmonary disease, cerebrovascular disease, poor
nutritional status, a predicted intraoperative period
greater than 6 h or predicted acute massive blood loss.
All of these criteria have been used in previous studies,
[2, 16] and they were adopted for this study. Patients
with severe aortic regurgitation, cardiac arrhythmias,
congestive heart failure, patients undergoing renal re-
placement therapy, those undergoing palliative surgery
were excluded from the study.
Patients were enrolled into a standard fluid resuscita-
tion period (Control group) or a goal-directed fluid-
management group based on pulse pressure variation
during the intervention period (Intervention group).
Following the control period, the three-month phase-out
period included education and preparation of all
anesthesiology staff and logistic arrangements for the
evaluation of fluid responsiveness using automated PPV
measurements. Finally, the intervention period was repli-
cated in the same season of the year as the control period.
Anesthesia care and fluid management
Intraoperative monitoring standards for high-risk pa-
tients in all institutions included electrocardiography,
invasive arterial blood pressure catheters, pulse oxim-
etry, temperature monitoring, and measurement of
inspiratory and expiratory gas concentrations. Additional
intraoperative monitoring such as central venous
catheterization was indicated on an individual basis by
the attending anesthesiologist. In the interventional
phase, however, intraoperative fluid adjustment was
strictly directed by online PPV assessment.
In the control period, patients were given intravenous
fluids at the discretion of the anesthesiologist based on
institutional protocol using 250 ml of crystalloids or
100 ml of colloids based on central venous pressure
(CVP) and mean arterial pressure (MAP) measure-
ments. The aim was to keep the CVP ≥ 8 mmHg and
MAP ≥ 65 mmHg. Fluid boluses were administered up
to a total of 1000 ml, if patients did not attain a MAP
of >65 mmHg, a vasopressor drug was administered.
During this initial phase, the anesthesiologists were
blind to the enrollment of the patient in the study. In
the interventional phase of the study, fluids boluses of
colloids were given to maintain continuously measured
PPV at 10% or less [13]. Some studies [17, 18] identified
different PPV cutoffs values and a higher cutoff value
may result in a substantial number of false-negative
results, meaning that necessary volume loading is with-
held from patients who would benefit from fluid
administration. When dealing with a population of
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high-risk surgical patients, fluid loading is more im-
portant to correct hemodynamic problem than in a
normal population. For this reason, a cutoff point based
on a PPV of 10% is justified.
In order to evaluate PPV during surgery, an arterial
line was connected to a monitor (DX 2020, Dixtal, São
Paulo, SP, Brasil) specifically developed to detect re-
spiratory variations in the arterial pressure curve,
allowing for the automatic calculation of beat to beat
pulse pressure, as previously described [13, 15]. PPV
was calculated using the following formula:
PPV ¼ 100 PPmax‐PPminð Þ= PPmaxþ PPminð Þ=2½ 
The mean value of PPV was automatically calculated
over three consecutive floating periods of eight respira-
tory cycles and the median value of this triple deter-
mination was displayed on the multiparameter monitor
and updated after each new respiratory cycle [13]. The
shape of the arterial curve was checked visually for
damping throughout the study period. The respective
hemodynamic protocols in both groups were continued
until the end of surgery.
In the interventional period, the mechanical ventilator
settings were adjusted using the following parameters: a)
a tidal volume of 8 mL.kg-1 (ideal body weight) in vol-
ume control mode; b) an inspiratory time of 33% of the
respiratory cycle; c) 5 cmH2O positive end expiratory
pressure and d) respiratory rate adjusted to maintain an
end-tidal capnometry of 35 mmHg to enable the meas-
urement of PPV.
During the postoperative period, critical care and
ward teams not involved in the intraoperative manage-
ment or in data collection managed the patients. These
individuals were not informed of patient allocation
groups or study period.
Data Collection and Monitoring
During the study, an investigator not participating in
patient care collected all study data prospectively up
until hospital discharge or patient death. Age, weight,
height, sex, comorbidities such as cirrhosis, chronic ob-
structive pulmonary disease, hypertension, peripheral
vascular disease, coronary artery disease, other cardiac
disease, diabetes mellitus and cerebrovascular disease
were recorded preoperatively as well as standard routine
biochemical blood tests were performed. Mechanical
ventilation settings, PPV values at 30 min’ intervals, the
use of vasopressors and inotropes and the duration of
surgery were recorded during intraoperative. Heart rate
(HR), mean arterial pressure (MAP), peripheral capillary
oxygen saturation (SpO2), hemoglobin concentration
and esophageal temperature were registered at the be-
ginning and at the end of the surgical procedure. When
available, central venous pressure (CVP) was recorded at
the end of the surgery. The total volumes of crystalloids,
colloids and blood products, percentage of patients re-
ceiving red blood cell transfusion, and use of vasopres-
sors and inotropic drugs were recorded.
After ICU admission and 24 h later, the following pa-
rameters were collected: HR, MAP, SpO2, CVP and ar-
terial lactate concentration. In the ICU, the total
volumes of infused crystalloids, colloids and hemocom-
ponents were recorded as well as the percentage of
patients receiving red blood cell pack (RBCP) unit
transfusion. Postoperative complications were assessed
daily until patient discharge according to previously
published criteria [13]: 1) vasopressor need was named
circulatory shock defined by the need for continuous
norepinephrine infusion after adequate fluid adjust-
ment; 2) major ICU infections (lung, abdominal, urin-
ary tract, line-related sepsis or wound infections); 3)
respiratory dysfunction, defined as recently as recent
partial pressure of oxygen in arterial blood/fraction of
inspired oxygen (FiO2) of <200 without prior patient
history; 4) need for reoperation; 5) need for mechanical
ventilation; 6) hematologic dysfunction, defined as a
platelet count of < 100,000/μL or prothrombin activity
of <50%; 7) bleeding events that needed transfusion of
platelets or coagulation factors; 8) renal dysfunction,
defined as a urine output of <500 mL/day, a serum cre-
atinine level of >1.9 mg/dL, or dialysis for acute renal
failure; and/or; 9) hepatic dysfunction, defined as a
serum bilirubin level of >1.9 mg/dL. Postoperative
length of stay and mortality were also recorded.
Upon completion of data collection from each patient,
an independent Data Safety and Monitoring Board
(DSMB) member conducted data quality monitoring by
comparing the collected study information to the infor-
mation contained in institutional medical records.
Data analysis
The primary outcome of this study was postoperative
length of hospital stay. The secondary outcomes
included the volume of infused fluids, RBCP transfusion,
incidence of organ dysfunction, incidence of postoperative
complications and a composite outcome encompassing
postoperative complications and hospital mortality rate.
According to the literature [19] and by using the minimal
clinically significant difference between groups, eighty-one
patients were required in each group to find a reduction
of 2 days (from 14 ± 5 days in the Control Group to 12 ±
4 days in the Intervention Group), with a Type-I error of
0.05 (one-sided) and a power of 0.8.
Normal data distribution was tested using the
Kolmogorov-Smirnov test. Continuous data were com-
pared between groups using Student’s t-tests or Wilcoxon
signed-rank test. Repeated measurement variables were
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studied over time using a generalized estimating equation
(GEE) model with the within factor being the time point
of the study and the grouping factor being the study
group. If main effects or interactions were significant, a
pairwise post-hoc analysis using the Šidák test was
performed. Binominal data were compared using chi-
squared analysis and Fisher’s exact test. The Mantel–
Haenszel hazard ratio and log-rank test were used to
compare the postoperative length of hospital stay between
the groups. The composite outcome was reported as an
odds ratio (OR), representing the OR of the occurrence of
at least one major complication over the odds of no occur-
rence of complications.
Controlling for confounding variables
Since data from the intervention and control groups
were collected in two distinct periods in a non-
randomized fashion, differences in patients’ baseline
characteristics could have led to biased estimates of
treatment effects. In order to balance the baseline char-
acteristics and reduce bias, we matched patients from
the intervention and control groups using a propensity
score, defined as the conditional probability of being
treated. First, a logistic regression model was created
using the group variable as the dependent variable.
Other potential confounding risk factors for morbidity
and length of stay considered in the analyses included
age, weight, time of surgery, and type of operation were
entered as predictors, and the width of the matching
tolerance caliper was set at 0.05 of the logit. Those vari-
ables were selected on matching by using a back-door
criterion, which detected the presence of confounding
variables. Then, a match for each intervention group
patient was selected from the control group based on
the closest logit. This model was constructed based on a
sample of patients matched by propensity score 1:1 with-
out replacement or repetition. The matching procedure
was performed before the analysis of the study outcomes.
Differences were considered significant at p <0.05. The
results are expressed as mean ± standard deviation, per-
centage, OR ± 95% confidence interval (CI) or as defined
otherwise. All analyses were conducted using IBM-SPSS
software (Version 21, IBM Corp. Armonk, NY, USA).
Results
Group allocation and matching
During the study period, 256 surgical patients were
enrolled (147 during the control period and 109 during
the intervention period) (Fig. 1). The baseline charac-
teristics of the patients are presented in Table 1. In the
original cohort, it was observed that the incidence of
non-dialytic renal failure, the white cell count, MAP
and duration of surgery were significantly greater than
in the PPV group, while the incidence of cirrhosis, tidal
volume and initial intraoperative hematocrit were
greater in the intervention group. The frequency of
surgical procedures was also unbalanced between the
groups (P = 0.04). After propensity score matching, 84
patients remained in each group and all the baseline
characteristics regarding comorbidities (Table 1) and
frequency of surgical procedures (Table 2) were well
balanced.
The overall mean age was 70 ± 7.1 years old, and
64% of the matched population were men, without
differences between groups. In the matched cohort,
53.6% of control group and 54.8% of intervention
group were classified as P2 patients according to the
American Society of Anesthesiology (ASA) classifica-
tion, while 45.2% in both groups were classified as P3
(P = 0.76). Two or more preoperative comorbidities
were present in 54.3% and 45.7% of the control and
intervention groups, respectively (P = 0.49).
Intraoperative physiological status, ventilator parameters
and hemodynamic management in the propensity
matched cohort
The duration of surgery, physiological parameters evalu-
ated at the start and end of the surgery and ventilator
settings used were similar in both groups (Table 2). In-
traoperative FiO2 was slightly higher in the control
group (50 ± 7% versus 48 ± 6%, P = 0.04) but not clinic-
ally relevant. At the end of surgery, central venous pres-
sure was 12 ± 3 mmHg in the control group and 11 ±
8 mmHg in the intervention group (P = 0.93). The mean
PPV was 7.4% in the intervention group throughout the
study, and remained below 10% in both the original and
matched cohorts. In the intervention group, the median
volume of crystalloids infused was significantly lower
than that in the control group (P = 0.01), as shown in
Table 2. Conversely, both groups received a similar vol-
ume of colloids (P = 0.33). The fraction of patients
receiving RBCP transfusion was similar in both groups
(P = 0.44), but a greater number of RBCP units were
transfused per patient in the control group (P = 0.01).
The need for vasopressor and inotropic drug infusion
and the hematocrit concentration measured at the end
of surgery were similar in both groups.
Postoperative outcomes in the propensity matched
cohort
Upon ICU admission and 24 h later, the MAP and HR
were similar in both groups (Table 3). However, the
median value of CVP was lower in the intervention
group after 24 h in the ICU (P = 0.002). The volume of
crystalloid solution infused (P = 0.001) and number of
patients receiving RBCP units (P = 0.003) on the first
postoperative day were significantly greater in the con-
trol group in comparison to the intervention group, as
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shown in Table 3. After 24 h in the ICU, 9.7% of pa-
tients in the control group still required mechanical
ventilation compared with 3.2% of the intervention
group (P = 0.027).
The postoperative complication odds ratios are shown
in Fig. 2. Despite a trend for an increased incidence of
cardiovascular dysfunction manifest in the need for
continuous infusion of vasopressors during the first 24 h
postoperatively in patients receiving fluids directed by
PPV monitoring (OR: 1.97; 95% CI: 0.97 – 3.96), postop-
erative arterial lactate concentrations, an indicator of
tissue hypoperfusion, were similar between the Control
and Intervention Groups upon ICU admission (P = 0.55)
and after 24 h (P = 0.41), as shown in Table 3. The inci-
dence hematological dysfunction was lower in the inter-
vention group (OR 0.26; CI 95% 0.1 – 0.64). A trend
towards a lower incidence of respiratory (OR: 0.54; 95%
CI: 0.2–1.46), renal (OR: 0.57; 95% CI: 0.24–1.35), and
hepatic (OR: 0.27; 95% CI: 0.05–1.33) organ failures in
the Intervention Group was also evident. Combining all
postoperative complications and hospital deaths into a
composite postoperative complication outcome revealed
that PPV-guided intraoperative fluid loading reduced the
morbidity of high-risk patients undergoing major surgi-
cal interventions (OR: 0.59; 95% CI: 0.35–0.99).
Although no differences were apparent in the median
length of ICU stay between the Control and Interven-
tion Groups (3 days (1 – 4) vs. 2 days (1 – 4); P = 0.29),
the median postoperative and hospital length of stay
were significantly shorter in the intervention group, as
shown in Table 3. The hazard ratio for the postopera-
tive length of hospital stay was 0.6 (95% CI: 0.42 - 0.88)
in the patients receiving intraoperative fluid loading
guided by PPV (Fig. 3). Mortality rates were not statisti-
cally different in the control (19%) and in intervention
(13.3%) groups.
Discussion
In this study, we observed that PPV-guided intraopera-
tive fluid loading was associated with a decrease in
postoperative complications and in hospital length of
stay. In addition, we observed a reduction in the
amount of fluids and RBCP units infused during sur-
gery and in the first 24 h postoperatively.
Goal-directed hemodynamic therapy (GDHT) aiming
to optimize intraoperative oxygen delivery has been
Fig. 1 Patient flow throughout the study
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shown to reduce the incidence of postoperative organ
dysfunction and improve short- and long-term out-
comes in high-risk surgical patients in several studies
[2, 7, 20–23]. In a meta-analysis of 31 studies published
in 2012 [24], the authors reported that GDHT reduced
the number of patients with postoperative complica-
tions and the length of hospital stay by 1.16 days.
Pearse et al. [25] included their data in an updated
meta-analysis, and showed that GDHT was associated
with a reduction in complication rates, postoperative
infections, and duration of hospital stay.
Despite growing evidence pointing to the role of such
hemodynamic optimization strategies to reduce the
incidence of postoperative morbidity in high-risk surgical
patients, the best intraoperative fluid management strat-
egy remains controversial [11, 26]. During surgery, hypo-
volemia occurs as a consequence of extended preoperative
fasting, bleeding and loss of fluids to the interstitium due
to the systemic inflammatory response [27]. Moreover,
general anesthesia blunts compensatory autonomic re-
sponses to an oxygen delivery/consumption mismatch.
Standard hemodynamic monitoring such as central
venous pressure monitoring and surrogates of tissue per-
fusion adequacy such as lactate and central venous satur-
ation have a low power to discriminate patients whose
cardiac output will increase in response to volume loading
[10, 28]. Furthermore, only monitoring surrogates of car-
diovascular performance without using a treatment algo-
rithm has proven to be ineffective in facilitating
hemodynamic stabilization or affecting outcome [29].
Our results showed that goal-directed fluid manage-
ment based on PPV monitoring during high-risk
surgery reduced the total amount of fluids given intra-
operatively and the blood transfusion volume while
arterial lactate concentrations measured immediately
after ICU admission and 24 h later were similar in both
Table 1 Baseline characteristics
Original Cohort Matched Cohort
Control (n = 147) Intervention (n = 109) P Control (n = 84) Intervention (n = 84) P
Male, n (%) 91 (61.9%) 73 (67%) 0.40 53 (63.1%) 54 (64.3%) 0.87
Age (y), mean ± SD 71.1 ± 7.4 69.5 ± 7.0 0.07 69.5 ± 7.2 70.5 ± 7.0 0.39
Weight (kg), mean ± SD 66.1 ± 14.2 66.3 ± 13.6 0.87 65.9 ± 13.5 65.7 ± 13.9 0.92
ASA Score 0.16 0.76
P 2 score, n (%) 74 (51.3%) 63 (57.8%) 45 (53.6%) 46 (54.8%)
P 3 score, n (%) 69 (46.9%) 46 (42.2%) 38 (45.2%) 38 (45.2%)
P 4 score, n (%) 4 (2.7%) - 1 (1.2%) -
Chronic diseases
Non-dialytic renal failure, n (%) 32 (21.9%) 14 (12.8%) 0.03 16 (19%) 9 (10.7%) 0.13
Cirrhosis, n (%) 1 (0.7%) 5 (4.6%) 0.04 1 (1.2%) 3 (3.6%) 0.31
Chronic obstructive pulmonary disease, n (%) 21 (14.3%) 17 (15.6%) 0.77 13 (15.5%) 11 (13.1%) 0.66
Hypertension, n (%) 112 (76.2%) 88 (71.6%) 0.40 64 (76.2%) 65 (77.4%) 0.85
Coronary artery disease, n (%) 46 (31.3%) 27 (24.8%) 0.25 22 (26.2%) 24 (28.6%) 0.73
Other cardiac disease, n (%) 9 (6.1%) 5 (4.6%) 0.59 4 (4.7%) 5 (5.9%) 0.73
Diabetes mellitus, n (%) 38 (25.8%) 28 (25.7%) 0.89 26 (30.9%) 22 (26.2%) 0.61
Preoperative biological tests
Blood urea nitrogen (mg/dL), mean ± SD 48.3 ± 24.7 43.2 ± 22.9 0.11 47.1 ± 22.3 42.6 ± 18.0 0.17
Creatinine (mg/dL), mean ± SD 1.3 ± 1.2 1.1 ± 0.7 0.25 1.2 ± 0.5 1.1 ± 0.7 0.62
Plasmatic sodium (mEq/L), mean ± SD 139 ± 4 138 ± 14 0.26 139 ± 4 139 ± 4 0.60
Plasmatic potassium (mEq/L), mean ± SD 4.4 ± 0.6 4.2 ± 0.4 0.07 4.3 ± 0.6 4.2 ± 0.5 0.76
Glucose (mg/dL), mean ± SD 110 ± 37 114 ± 39 0.58 120 ± 53 106 ± 31 0.17
Hemoglobin (mg/dL), mean ± SD 12.4 ± 1.9 12.4 ± 1.9 0.99 12.3 ± 1.9 12.2 ± 1.9 0.69
Hematocrit (%), mean ± SD 38.2 ± 5.5 37.6 ± 5.2 0.41 38.0 ± 5.8 37.2 ± 5.2 0.38
Platelets (count/μL), mean ± SD 248 ± 112 251 ± 04 0.85 250 ± 112 249 ± 104 0.93
Leukocytes (count/mL), mean ± SD 8002 ± 3355 6814 ± 2375 0.01 7805 ± 2910 6646 ± 2322 0.06
INR, mean ± SD 1.0 ± 0.2 1.0 ± 0.2 0.95 1.0 ± 0.2 1.1 ± 0.2 0.23
Legends: ASA American Association of Anesthesiologists, INR international normalized ratio
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groups. These findings point to a thoroughly different
scene from previous GDHT studies in which the con-
trol groups presented intraoperative hypoperfusion and
consequent worse outcomes [4, 13, 30]. The comprehen-
sion of intraoperative hypoperfusion as the underlying
mechanism of postoperative organ failure and the conse-
quent need to maintain adequate intraoperative oxygen
transport raises a new question in intraoperative fluid
management, it means, how much fluid is enough to
optimize tissue perfusion and prevent postoperative organ
dysfunction while avoiding unwanted consequences. In a
recent study [9], it was observed that excessive intraopera-
tive fluid infusion resulted in greater organ dysfunction
and infection rates in high-risk surgical patients. Other
authors have also reported the same association between
excessive fluid infusion and increased mortality, morbidity
and length of hospital stay in this population [2, 31].
However, in contrast to previous studies comparing re-
strictive versus liberal intraoperative fluid therapy, [32, 33]
by using PPV to guide fluid resuscitation, we were able to
maximize cardiac performance and oxygen delivery while
avoiding complications associated with fluid overload.
Apart, in a pilot study using a before-and-after meth-
odology of PPV in patients undergoing cardiac surgery,
Suzuki et [34] found a small increase in the amount of
fluids given by using PPV method, but there was very
Table 2 Intraoperative data on control and intervention groups
Original Cohort Matched Cohort
Control (n = 147) Intervention (n = 109) P Control (n = 84) Intervention (n = 84) P
Type of surgery 0.04 0.48
Gastrointestinal, n (%) 47 (32%) 59 (53.2%) 29 (34.3%) 47 (56%)
Gynecological, n (%) 7 (4.8%) 3 (2.3%) 1 (1.2%) 3 (3.6%)
Vascular, n (%) 65 (44.2%) 26 (23.9%) 39 (46.4%) 21 (25%)
Urological, n (%) 15 (10.2%) 21 (19.3%) 10 (11.9%) 13 (15.5%)
Combined interventions, n (%) 13 (8.8%) 1 (0.9%) 5 (6%) -
Respiratory settings
PEEP (mmHg), mean ± SD 5.3 ± 1.5 5.5 ± 1 .1 0.47 5.2 ± 1.8 5.4 ± 1.1 0.31
Tidal volume (mL/kg), mean ± SD 7.6 ± 1.4 8.1 ± 1.2 0.003 7.7 ± 1.2 8.2 ± 1.2 0.05
RR (breaths/min), mean ± SD 11.5 ± 1.2 11.5 ± 1.2 0.94 11.5 ± 1.3 11.5 ± 1.2 0.92
FiO2 (%), mean ± SD 49 ± 8 49 ± 7 0.52 50 ± 7 48 ± 6 0.04
Physiologic status at start of surgery
HR (BPM), mean ± SD 76 ± 13 71 ± 15 0.28 71 ± 12 71 ± 15 0.86
MAP (mmHg), mean ± SD 97 ± 15 88 ± 17 0.03 100 ± 11 91 ± 17 0.06
SpO2 (%), mean ± SD 95 ± 7 97 ± 2 0.10 95 ± 10 97 ± 2 0.11
Hematocrit (%), mean ± SD 29 ± 6 34 ± 7 0.03 30 ± 5 32 ± 7 0.24
Physiologic status at end of surgery
HR (BPM), mean ± SD 74 ± 14 73 ± 14 0.52 74 ± 13 72 ± 13 0.45
MAP (mmHg), mean ± SD 83 ± 13 79 ± 16 0.11 82 ± 14 80 ± 16 0.65
CVP (mmHg), mean ± SD 12 ± 4 11 ± 7 0.68 12 ± 3 11 ± 8 0.93
SpO2 (%), mean ± SD 98 ± 1 98 ± 1 0.42 98 ± 1 98 ± 1 0.95
Hematocrit (%), mean ± SD 34 ± 6 33 ± 6 0.65 34 ± 6 33 ± 5 0.40
Fluid administered intraoperatively
Crystalloids (mL), median (IQ 25–75) 4500 (3000–7000) 5200 (3500–6850) 0.24 5000 (3750–8862) 4500 (3200-6500) 0.01
Colloids (mL), median (IQ 25–75) 1000 (500-1000) 900 (500-1000) 0.46 1000 (500-1000) 900 (500-1000) 0.33
Number of patients transfused, n (%) 64 (43.5%) 51 (46.8%) 0.6 44 (52.4%) 39 (46.4%) 0.44
RBCP units/patient, median (IQ 25–75) 1.7 (0.9–2.5) 1.7 (0.9–2.0) 0.08 2.0 (1.7–2.6) 1.7 (0.9–2.0) 0.01
Intraoperative noradrenaline, n (%) 10 (6.8%) 18 (16.5%) 0.01 5 (3%) 9 (5.4%) 0.4
Intraoperative dobutamine, n (%) 2 (1.4%) 7 (6.4%) 0.04 1 (0.6%) 5 (3%) 0.21
Surgery length (min), mean ± SD 324 ± 147 410 ± 165 0.001 349 ± 141 355 ± 130 0.39
Legends: PEEP positive end-expiratory pressure, RR respiratory rate, FiO2 Inspired oxygen fraction, HR heart rate, MAP mean arterial pressure, CVP central venous
pressure, SpO2oxygen saturation measured by pulse oximetry, RBCP red blood cell pack
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little evidence of any difference in physiologic or clin-
ical outcomes.
Our study has some important limitations that
require careful interpretation. First of all, it was not a
blinded randomized trial. Unfortunately, it is practic-
ally impossible for it to be blinded, because the evalu-
ation of intraoperative hemodynamic interventions
using online monitoring devices may introduce obser-
ver bias into randomized controlled trials. Therefore,
we designed a prospective before-and-after study with
an “anesthesiologist-blinded” in control group to
evaluate the impact of intraoperative PPV-guided fluid
management on postoperative outcomes instead of a
standard randomized controlled trial. It would be
practically impossible to blind the study intervention,
since the arterial pressure curve must be on the
monitor to enable anesthesiologists to assess the qual-
ity of pressure monitoring. Hence, a mere glance at
the arterial pressure waveform would give information
on fluid responsiveness and potentially alter the way
that fluid therapy decisions were made in the Control
Group [35]. Moreover, the simple fact of knowing
Fig. 2 Odds ratios and 95% confidence intervals for clinical outcomes
Table 3 Postoperative outcomes
Original Cohort Matched Cohort
Control (n = 147) Intervention (n = 109) P Control (n = 84) Intervention (n = 84) P
At the time of ICU admission
HR (BPM), mean ± SD 77 ± 16 79 ± 14 0.51 79 ± 16 77 ± 14 0.40
MAP (mmHg), mean ± SD 93 ± 20 89 ± 20 0.25 89 ± 22 90 ± 20 0.77
Lactate (mmol/l), median (IQ 25–75) 2.1 (1.5 - 3.5) 2.6 (1.8 - 3.7) 0.48 2.6 (1.8-4.3) 2.5 (1.5-3.2) 0.55
CVP (mmHg) median (IQ 25–75) 10 (6.2 - 13.0) 9 (5 – 10) 0.04 10 (6.0 – 13) 9 (5-10) 0.13
At 24 h after ICU admission
HR (BPM), mean ± SD 80.3 ± 16.4 83.5 ± 17.3 0.15 82.3 ± 15.9 81.9 ± 16.3 0.87
MAP (mmHg), mean ± SD 85.4 ± 15.1 81.7 ± 13.8 0.08 86.2 ± 15.4 82. 7 ± 14.4 0.21
Lactate (mmol/l), median (IQ 25–75) 2.4 (1.8 - 3.2) 1.8 (0.7 - 2.7) 0.07 2.3 (1.6-2.9) 2.3 (1.1-2.7) 0.41
CVP (mmHg), median (IQ 25–75) 11 (8.0 – 15) 8 (6.0 - 10.2) 0.00 12 (8.5-15) 8 (6.25-11) 0.002
Fluid administered in first 24 h
Crystalloids (mL), median (IQ 25–75) 3630 (2685 - 4822) 3500 (2412- 4450) 0.13 4343 (3154- 5620) 3515 (2400 - 4270) 0.00
Colloids (mL), median (IQ 25–75%) 500 (500 - 1000) 500 (500 - 500) 0.09 500 (500 - 1000) 500 (500 - 500) 0.23
Number of patients transfused, n (%) 41 (27.9%) 17 (15.6%) 0.02 27 (32.1%) 11 (13.1%) 0.003
RBCP units/patient, median (IQ 25–75) 1.7 (0.8 – 2.0) 1.0 (0.8 – 2.6) 0.71 0.8 (0.8 – 2.4) 1.0 (0.8 - 3.5) 0.44
ICU LOS (d), median (IQ 25–75) 2 (1-4) 2 (1-4) 0.59 3 (1 – 4) 2 (1 – 4) 0.29
Postoperative LOS (d), median (IQ 25–75) 9 (6-15) 8 (6.25-14) 0.83 11 (7 – 18) 8 (6 – 14) 0.01
Hospital LOS (d), median (IQ 25–75) 17 (11-26) 16 (9-25) 0.30 22 (13 - 30.75) 15 (9 - 23.75) 0.01
Hospital mortality rate 26 (17.7%) 16 (14.8%) 0.54 16 (19.0%) 11 (13.3%) 0.31
Legends: HR heart rate, MAP mean arterial pressure, CVP central venous pressure, SpO2 peripheral oxygen saturation, RBCP red blood cell pack, ICU intensive care
unit, LOS Length of Stay
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that patients were included in a study would modify
the way caregivers guide therapy of the control group
(Hawthorne effect), therefore distorting the true im-
pact of intraoperative PPV-guided intervention. Con-
versely, we enrolled patients at the same time of the
year, ruling out a seasonal effect. Taking into account
these issue, a before-and-after evaluation is the most
appropriate design to investigate intraoperative PPV-
guided fluid administration.
Second, nonetheless, the absence of randomization
introduces other problems such as the possibility of
selection bias from data collected in two distinct pe-
riods and imbalances between the groups leading to
biased estimates of treatment effects. In order to bal-
ance the baseline characteristics and reduce bias, we
matched patients from the intervention and control
groups using 1:1 propensity score matching without
repetition, even though there is the risk of unmeasured
confounding in the propensity score matched analysis.
While the sample included in this study was relatively
small and the caliper used to match the groups was
0.05 of the logit of the logistic regression model, the
groups were well balanced. Nevertheless, propensity
scoring is limited by calculating the probability of re-
ceiving the treatment based on observed and measured
variables. Hence, although superior to traditional co-
variance analysis methods used to decrease bias in ob-
servational data, it does not account for unobserved
covariates that may be relevant but not present in the
dataset but assumes that the probability is based solely
on the covariate score. Lastly, since the project design
was older, some definitions about complication/
outcomes did not follow current recommendations in
perioperative outcome measures [36].
Conclusion
In summary, these findings suggest that the intraopera-
tive use of PPV minimally invasive monitoring and a
fluid optimization protocol seems to decrease post-
operative complications and hospital length of stay.
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